Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
JCR Pharmaceuticals Co., Ltd. ( (JP:4552) ) has issued an announcement.
JCR Pharmaceuticals announced its participation in the 21st Annual WORLDSymposium 2025 in San Diego, where it will present data on its investigational therapies. The presentations will focus on JCR’s J-Brain Cargo® technology, which facilitates the delivery of treatments across the blood-brain barrier for lysosomal storage disorders. This participation highlights JCR’s innovative approach in addressing unmet medical needs in neurodegenerative and lysosomal storage disorders, potentially strengthening its position in the pharmaceutical industry.
More about JCR Pharmaceuticals Co., Ltd.
JCR Pharmaceuticals Co., Ltd. is a global specialty pharmaceuticals company focused on rare and genetic diseases. With a 49-year legacy in Japan, the company is expanding its reach to the US, Europe, and Latin America, utilizing scientific expertise and proprietary technologies to develop next-generation therapies.
YTD Price Performance: -6.26%
Average Trading Volume: 387,613
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: Yen68.06B
Find detailed analytics on 4552 stock on TipRanks’ Stock Analysis page.
